Department of Occupational Medicine, Swiss National Insurance Fund Suva, Fluhmattstr. 1, CH 6002 Lucerne, Switzerland.
J Occup Med Toxicol. 2014 May 14;9:21. doi: 10.1186/1745-6673-9-21. eCollection 2014.
Isocyanates are among the most common causes of occupational asthma (OA) in Switzerland. Patients with OA have been shown to have unfavourable medical, socioeconomic and psychological outcomes. We investigated long-term asthma and the socio-economic outcomes of diisocyanate-induced asthma (DIA) in Switzerland.
We conducted an observational study on 49 patients with DIA and followed 35 of these patients over a mean exposure-free interval of 12 ± 0.5 (range 11.0-13.0) years. At the initial and follow-up examinations, we recorded data on respiratory symptoms and asthma medication; measured the lung function; and tested for bronchial hyperreactivity. We allowed the patients to assess their state of health and overall satisfaction using a visual analogue scale (VAS) at these visits.
The 35 patients whom we could follow had a median symptomatic exposure time of 12 months, interquartile range (IQR) 26 months and a median overall exposure time of 51 (IQR 104) months. Their subjective symptoms (p < 0.001) and the use of asthma medication (p = 0.002), particularly the use of inhaled corticosteroids (p < 0.001), decreased by nearly 50%. At the same time, the self-assessment of the patients' state of health and overall satisfaction increased considerably according to both symptomatology and income. In contrast, slight reductions in terms of FVC% predicted from 102% to 96% (p = 0.04), of FEV1% predicted from 91% to 87% (p = 0.06) and of the FEV1/FVC ratio of 3%; (p = 0.01) were observed while NSBHR positivity did not change significantly. In univariate as well as multivariate logistic analyses we showed significant associations between age, duration of exposure and FEV1/FVC ratio with persistent asthma symptoms and NSBHR.
We found that the patients' symptoms, the extent of their therapy and the decrease in their lung volumes during the follow-up period were similar to the findings in the literature. The same hold true for some prognostic factors, whereas the patients' self-assessment of their state of health and overall satisfaction improved considerably.
异氰酸酯是瑞士职业性哮喘(OA)最常见的病因之一。OA 患者的医疗、社会经济和心理结局较差。我们调查了瑞士二异氰酸酯(DIA)引起的哮喘的长期哮喘和社会经济结局。
我们对 49 例 DIA 患者进行了一项观察性研究,并对其中 35 例患者进行了平均无暴露间隔 12 ± 0.5(范围 11.0-13.0)年的随访。在初始和随访检查时,我们记录了呼吸症状和哮喘药物使用情况;测量了肺功能;并进行了支气管高反应性测试。在这些就诊时,患者使用视觉模拟量表(VAS)评估他们的健康状况和整体满意度。
我们可以随访的 35 例患者的中位症状性暴露时间为 12 个月,四分位距(IQR)为 26 个月,总暴露时间为 51(IQR 104)个月。他们的主观症状(p < 0.001)和哮喘药物使用(p = 0.002),特别是吸入皮质类固醇(p < 0.001)的使用减少了近 50%。与此同时,根据症状和收入,患者对自己健康状况和整体满意度的自我评估都有了相当大的提高。相比之下,FVC%预测值从 102%降至 96%(p = 0.04)、FEV1%预测值从 91%降至 87%(p = 0.06)和 FEV1/FVC 比值 3%(p = 0.01)的轻度下降,而 NSBHR 阳性率无显著变化。在单变量和多变量逻辑分析中,我们发现年龄、暴露时间和 FEV1/FVC 比值与持续性哮喘症状和 NSBHR 之间存在显著关联。
我们发现患者的症状、治疗程度和随访期间肺容积的下降与文献中的发现相似。一些预后因素也是如此,而患者对自己健康状况和整体满意度的自我评估则有了很大的提高。